These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37927813)

  • 1. Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival.
    Meleshko A; Kushniarova L; Shinkevich V; Mikhaleuskaya T; Valochnik A; Proleskovskaya I
    Cancer Diagn Progn; 2023; 3(6):695-705. PubMed ID: 37927813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
    Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
    Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
    Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of β-catenin and paired-like homeobox 2B (PHOX2B) expression in neuroblastoma patients; predictive and prognostic value.
    El-Shazly SS; Hassan NM; Abdellateif MS; El Taweel MA; Abd-Elwahab N; Ebeid EN
    Exp Mol Pathol; 2019 Oct; 110():104272. PubMed ID: 31220430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
    Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
    Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
    Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
    [No Abstract]   [Full Text] [Related]  

  • 8. RT-qPCR for
    Grèze V; Kanold J; Chambon F; Halle P; Gremeau AS; Rives N; Rouel N; Pereira B; Tchirkov A; Brugnon F
    Oncol Lett; 2017 Jul; 14(1):860-866. PubMed ID: 28693243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma.
    Fan H; Xing T; Hong H; Duan C; Zhao W; Zhao Q; Wang X; Huang C; Zhu S; Jin M; Su Y; Gao C; Ma X
    Pediatr Hematol Oncol; 2022 May; 39(4):343-356. PubMed ID: 34752187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors.
    Corrias MV; Haupt R; Carlini B; Cappelli E; Giardino S; Tripodi G; Tonini GP; Garaventa A; Pistoia V; Pistorio A
    Pediatr Blood Cancer; 2012 Jan; 58(1):43-9. PubMed ID: 21254375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.
    Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Yalcin B; Dee R; van Noesel MM; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
    Clin Chem; 2009 Jul; 55(7):1316-26. PubMed ID: 19460840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.
    Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
    Warren M; Matsuno R; Tran H; Shimada H
    Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
    Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
    Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples.
    Ognibene M; Cangelosi D; Sorrentino S; Zanardi S; Zara F; Pezzolo A; Parodi S
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29800. PubMed ID: 35652628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
    Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of survivin mRNA expression in prognosis of neuroblastoma.
    Ito R; Asami S; Motohashi S; Ootsuka S; Yamaguchi Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2005 Apr; 28(4):565-8. PubMed ID: 15802787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.
    Hemminger JA; Toland AE; Scharschmidt TJ; Mayerson JL; Guttridge DC; Iwenofu OH
    Mod Pathol; 2014 Sep; 27(9):1238-45. PubMed ID: 24457462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
    Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
    J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.